Treating disorders by application of insulin-like growth factors and analogs
US6693076B1 · kind B1 · utility
4Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 1999 |
| Grant date | Feb 17, 2004 |
| Priority date | — |
| Expiry date | Aug 21, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.